Loading…
The evolving landscape of anatomic pathology
Anatomic pathology has changed dramatically in recent years. Although the microscopic assessment of tissues and cells is and will remain the mainstay of cancer diagnosis molecular profiling has become equally relevant. Thus, to stay abreast of the evolving landscape of today’s anatomic pathology, mo...
Saved in:
Published in: | Critical reviews in oncology/hematology 2022-10, Vol.178, p.103776-103776, Article 103776 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Anatomic pathology has changed dramatically in recent years. Although the microscopic assessment of tissues and cells is and will remain the mainstay of cancer diagnosis molecular profiling has become equally relevant. Thus, to stay abreast of the evolving landscape of today’s anatomic pathology, modern pathologists must be able to master the intricate world of predictive molecular pathology. To this aim, pathologists have had to acquire additional knowledge to bridge the gap between clinicians and molecular biologists. This new role is particularly important, as cases are now collegially discussed in molecular tumor boards (MTBs). Moreover, as opposed to traditional pathologists, modern pathologists have also adamantly embraced innovation while keeping a constant eye on tradition. In this article, we depict the highlights and shadows of the upcoming “Anatomic Pathology 2.0” by placing particular emphasis on the pathologist’s growing role in the management of cancer patients.
[Display omitted]
•Anatomic pathology has changed dramatically in recent years.•Molecular profiling has become equally relevant to microscopic evaluation in modern Anatomic Pathology.•Modern pathologists must be able to master the intricate world of predictive molecular pathology.•This new role is particularly important, as cases are now collegially discussed in molecular tumor boards. |
---|---|
ISSN: | 1040-8428 1879-0461 |
DOI: | 10.1016/j.critrevonc.2022.103776 |